financetom
Business
financetom
/
Business
/
Avidity Biosciences Insider Sold Shares Worth $767,780, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avidity Biosciences Insider Sold Shares Worth $767,780, According to a Recent SEC Filing
Jun 5, 2024 3:22 PM

05:54 PM EDT, 06/05/2024 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on June 04, 2024, sold 28,000 shares in Avidity Biosciences ( RNA ) for $767,780. Following the Form 4 filing with the SEC, Boyce has control over a total of 112,117 shares of the company, with 112,117 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990124000077/xslF345X03/wk-form4_1717623967.xml

Price: 27.70, Change: -0.24, Percent Change: -0.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved